Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery

American Journal of Cardiology

Volumn 109, Issue 9, 2012, Pages 1384-1385

  Petricevic, Mate ^a   Biocina, Bojan ^a   Gasparovic, Hrvoje ^a   Ivancan, Visnja ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

BLEEDING; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; DRUG WITHDRAWAL; HEART MUSCLE ISCHEMIA; HEART VALVE SURGERY; HOSPITAL INFORMATION SYSTEM; MORBIDITY; MORTALITY; NOTE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; THROMBOCYTE FUNCTION; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84859801620     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.008     Document Type: Letter

References (4)

1. Jacob M, Smedira N, Blackstone E, Williams S, Cho L. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in patients having combined coronary artery bypass grafting and valve surgery. Am J Cardiol 2011;109:824-830.
2. Ben-Dor I, Kleiman NS, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol 2009;104:227-233.
3. Petricevic M, Biocina B, Konosic S, Kopjar T, Kunac N, Gasparovic H. Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy. Heart Vessels 2011. [Epub ahead of print]. doi:10.1007/s00380-011-0216-3.
4. Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer RM Jr. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 2002;235:820-827. (Pubitemid 34547300)